BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 11096213)

  • 1. Autoantibodies in patients with Lupus erythematosus: spectrum and frequencies.
    Wenzel J; Bauer R; Bieber T; Böhm I
    Dermatology; 2000; 201(3):282-3. PubMed ID: 11096213
    [No Abstract]   [Full Text] [Related]  

  • 2. Distinguishing subacute cutaneous from other types of lupus erythematosus.
    McCauliffe DP
    Lancet; 1998 May; 351(9115):1527-8. PubMed ID: 10326532
    [No Abstract]   [Full Text] [Related]  

  • 3. Thyroid autoantibodies in the subsets of lupus erythematosus: correlation with other autoantibodies and thyroid function.
    Konstadoulakis MM; Kroubouzos G; Tosca A; Piperingos G; Marafelia P; Konstadoulakis M; Varelzidis A; Koutras DA
    Thyroidology; 1993 Apr; 5(1):1-7. PubMed ID: 7508737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin tests with nuclear factors in systemic lupus erythematosus.
    Jones HE; Derbes VJ; Gum OB; Azoury FJ
    Arch Dermatol; 1967 Jun; 95(6):559-64. PubMed ID: 5338435
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-Ro antibodies and neonatal lupus.
    Petri M; Watson R; Hochberg MC
    Rheum Dis Clin North Am; 1989 May; 15(2):335-60. PubMed ID: 2657894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection of SSA/Ro antibody in patients with systemic lupus erythematosus, discoid lupus erythematosus and cutaneous photosensitivity. A comparative study].
    Carazzai AM; Sucena RC; Milano SI; Munhoz EG; Santos RA; Scheinberg MA
    Rev Paul Med; 1988; 106(2):71-4. PubMed ID: 3148992
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti C1q antibodies in cutaneous lupus erythematosus.
    Bălănescu E; Tănăsescu C; Bălănescu P; Olteanu R; Badea C; Petruţescu B; Grancea C; Vagu C; Bleotu C; Ruţă S; Ardeleanu C
    Rom J Intern Med; 2010; 48(2):159-63. PubMed ID: 21428180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Routine immunofluorescence studies for demonstration of antinuclear factors].
    Hiemann D
    Z Gesamte Inn Med; 1969 May; 24(10):150-1. PubMed ID: 4185287
    [No Abstract]   [Full Text] [Related]  

  • 9. Lupus erythematosus: laboratory testing and clinical subsets in the evaluation of patients.
    Synkowski DR; Mogavero HS; Provost TT
    Med Clin North Am; 1980 Sep; 64(5):921-40. PubMed ID: 6159506
    [No Abstract]   [Full Text] [Related]  

  • 10. [Lupus erythematosus].
    Goerz G; Lehmann P; Schuppe HC; Lakomek HJ; Kind P
    Z Hautkr; 1990 Mar; 65(3):226, 229-34. PubMed ID: 2339576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cutaneous lupus erythematosus and cardiolipin antibodies. Incidence and clinical significance].
    Kind P; Schuppe HC; Jung KP; Degitz K; Lakomek HJ; Goerz G
    Hautarzt; 1992 Mar; 43(3):126-9. PubMed ID: 1577599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of the anti-Ro (SS-A) antibody in evaluation of patients with cutaneous manifestations of a connective tissue disease.
    Provost TT; Watson R; Simmons-O'Brien E
    J Am Acad Dermatol; 1996 Aug; 35(2 Pt 1):147-69; quiz 170-2. PubMed ID: 8708014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection of circulating antibodies in the blood and immune complex precipitates of patients with autoimmune diseases (preliminary report)].
    Kiss M; Husz S; Dobozy A
    Orv Hetil; 1992 May; 133(18):1103-4, 1109-10. PubMed ID: 1579350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies in patients with oral lupus erythematosus, lichen planus and leukoplakia. An aid in diagnosis.
    Schiødt M; Permin H; Wiik A; Manthorpe R
    Acta Pathol Microbiol Immunol Scand C; 1983 Feb; 91(1):59-63. PubMed ID: 6603096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer cell activity of peripheral blood mononuclear cells from patients with various forms of lupus erythematosus.
    Błaszczyk M; Majewski S; Wasik M; Chorzelski T; Jabłonska S
    Br J Dermatol; 1987 Dec; 117(6):709-14. PubMed ID: 3426951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum antinuclear antibodies (in patients with visceral erythematodes, rheumatoid arthritis, progressive systemic sclerosis and discoid erythematodes)].
    Horvat Z
    Acta Med Iugosl; 1970; 24(3):229-40. PubMed ID: 4928076
    [No Abstract]   [Full Text] [Related]  

  • 17. Commentary: neonatal lupus erythematosus.
    Provost TT
    Arch Dermatol; 1983 Jul; 119(7):619-22. PubMed ID: 6602590
    [No Abstract]   [Full Text] [Related]  

  • 18. Conversion of discoid lupus erythematosus to mixed connective tissue disease.
    Gilliam JN; Prystowsky SD
    J Rheumatol; 1977; 4(2):165-9. PubMed ID: 881692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunopathological studies of intradermal tests with DNA in lupus erythematosus].
    Wranicz A
    Przegl Dermatol; 1972; 59(2):183-8. PubMed ID: 4537151
    [No Abstract]   [Full Text] [Related]  

  • 20. Study of cutaneous lupus erythematosus by immunohistochemical methods.
    Pohle EL; Tuffanelli DL
    Arch Dermatol; 1968 May; 97(5):520-6. PubMed ID: 4171670
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.